{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:45:50Z","timestamp":1783766750430,"version":"3.55.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.xcrm.2024.101591","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T14:58:49Z","timestamp":1717599529000},"page":"101591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of\u00a0individuals with recent-onset type 1 diabetes"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4374-8564","authenticated-orcid":false,"given":"Guido","family":"Sebastiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina Emanuela","family":"Grieco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bruttini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Auddino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Toniolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Fignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Licata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Nigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Formichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fernandez-Tajes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmella","family":"Evans-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lut","family":"Overbergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Tree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Peakman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4947-7478","authenticated-orcid":false,"given":"Francesco","family":"Dotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2024.101591_bib1","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2337\/dc22-S002","article-title":"2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes\u20142022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xcrm.2024.101591_bib2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41574-019-0254-y","article-title":"The heterogeneous pathogenesis of type 1 diabetes mellitus","volume":"15","author":"Ilonen","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.xcrm.2024.101591_bib3","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.2337\/db17-0261","article-title":"The influence of type 1 diabetes genetic susceptibility regions, age, sex, and family history on the progression from multiple autoantibodies to type 1 diabetes: A TEDDY study report","volume":"66","author":"Krischer","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2024.101591_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2337\/dc19-0803","article-title":"Genetic Variants Predisposing Most Strongly to Type 1 Diabetes Diagnosed Under Age 7 Years Lie Near Candidate Genes That Function in the Immune System and in Pancreatic \u03b2-Cells","volume":"43","author":"Inshaw","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xcrm.2024.101591_bib5","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00125-012-2472-x","article-title":"Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes","volume":"55","author":"Ziegler","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.xcrm.2024.101591_bib6","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2337\/dc17-0238","article-title":"Genetic and Environmental Interactions Modify the Risk of Diabetes-Related Autoimmunity by 6 Years of Age: The TEDDY Study","volume":"40","author":"Krischer","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xcrm.2024.101591_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11892-018-1083-4","article-title":"The effect of age on the progression and severity of type 1 diabetes: potential effects on disease mechanisms","volume":"18","author":"Leete","year":"2018","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.xcrm.2024.101591_bib8","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.2337\/db11-1538","article-title":"Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes\u00a0TrialNet data","volume":"61","author":"Greenbaum","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2024.101591_bib9","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.2337\/dc16-0360","article-title":"Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose","volume":"39","author":"Hao","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xcrm.2024.101591_bib10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2337\/db15-0779","article-title":"Insulitis and \u03b2-Cell Mass in the Natural History of Type 1 Diabetes","volume":"65","author":"Campbell-Thompson","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2024.101591_bib11","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00125-023-05888-6","article-title":"The extent and magnitude of islet T\u00a0cell infiltration as powerful tools to define the progression to type 1 diabetes","volume":"66","author":"Apaolaza","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.xcrm.2024.101591_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3264","article-title":"From immunohistological to anatomical alterations of human pancreas in type 1 diabetes: New concepts on the stage","volume":"36","author":"Nigi","year":"2020","journal-title":"Diabetes. Metab. Res. Rev."},{"key":"10.1016\/j.xcrm.2024.101591_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.815703","article-title":"The prevalence of islet autoantibodies in children and adolescents with type 1 diabetes mellitus: A global scoping review","volume":"13","author":"Ross","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.xcrm.2024.101591_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/dc19-0880","article-title":"Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes","volume":"43","author":"Battaglia","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xcrm.2024.101591_bib15","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.2337\/db15-1615","article-title":"Differential Insulitic Profiles Determine the Extent of \u03b2-Cell Destruction and the Age at Onset of Type 1 Diabetes","volume":"65","author":"Leete","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2024.101591_bib16","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.2337\/db14-0365","article-title":"Blood and islet phenotypes indicate immunological heterogeneity in\u00a0type 1 diabetes","volume":"63","author":"Arif","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2024.101591_bib17","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s00125-020-05115-6","article-title":"Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis","volume":"63","author":"Leete","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.xcrm.2024.101591_bib18","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-015-3514-y","article-title":"The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study","volume":"58","author":"Krischer","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.xcrm.2024.101591_bib19","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.2337\/dc19-2547","article-title":"Hierarchical order of distinct autoantibody spreading and progression to type 1 diabetes in the TEDDY study","volume":"43","author":"Vehik","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xcrm.2024.101591_bib20","article-title":"Personalized immunotherapies for type 1 diabetes: who, what, when, and how?","volume":"12","author":"Deligne","year":"2022","journal-title":"J.\u00a0Pers. Med."},{"key":"10.1016\/j.xcrm.2024.101591_bib21","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1007\/s00125-018-4726-8","article-title":"Immunological biomarkers for the development and progression of type 1 diabetes","volume":"61","author":"Mathieu","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.xcrm.2024.101591_bib22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101591_bib23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0092-8674(93)90530-4","article-title":"Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans","volume":"75","author":"Wightman","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101591_bib24","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nrg2455","article-title":"Biological principles of microRNA-mediated\u00a0regulation: shared themes amid diversity","volume":"9","author":"Flynt","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.xcrm.2024.101591_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/749734","article-title":"MicroRNAs: Novel Players in the Dialogue between Pancreatic Islets and Immune System in Autoimmune Diabetes","volume":"2015","author":"Ventriglia","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.xcrm.2024.101591_bib26","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2337\/db11-1086","article-title":"Changes in microRNA expression contribute to pancreatic \u03b2-cell dysfunction in prediabetic NOD mice","volume":"61","author":"Roggli","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2024.101591_bib27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2337\/db16-0592","article-title":"MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p Regulate the Expression of Proapoptotic BH3-Only Proteins DP5 and PUMA in Human Pancreatic \u03b2-Cells","volume":"66","author":"Grieco","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2024.101591_bib28","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1038\/s41598-017-07172-1","article-title":"Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression","volume":"7","author":"Sebastiani","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2024.101591_bib29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cmet.2018.09.011","article-title":"Lymphocyte-Derived Exosomal MicroRNAs Promote Pancreatic \u03b2 Cell Death and May Contribute to Type 1 Diabetes Development","volume":"29","author":"Guay","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2024.101591_bib30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s00125-019-05026-1","article-title":"miR-409-3p is reduced in\u00a0plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes","volume":"63","author":"Ventriglia","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.xcrm.2024.101591_bib31","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/dmrr.1262","article-title":"Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity","volume":"27","author":"Sebastiani","year":"2011","journal-title":"Diabetes. Metab. Res. Rev."},{"key":"10.1016\/j.xcrm.2024.101591_bib32","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2141.2008.07077.x","article-title":"Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma","volume":"141","author":"Lawrie","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.xcrm.2024.101591_bib33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1373\/clinchem.2007.097972","article-title":"Detection and characterization of placental microRNAs in maternal plasma","volume":"54","author":"Chim","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.xcrm.2024.101591_bib34","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature21365","article-title":"Adipose-derived circulating miRNAs regulate gene expression in other tissues","volume":"542","author":"Thomou","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101591_bib35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s40618-017-0611-4","article-title":"Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging?","volume":"40","author":"Sebastiani","year":"2017","journal-title":"J.\u00a0Endocrinol. Invest."},{"key":"10.1016\/j.xcrm.2024.101591_bib36","article-title":"Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression","volume":"2012","author":"Nielsen","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.xcrm.2024.101591_bib37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00125-016-4156-4","article-title":"Circulating microRNA levels predict residual beta cell function and glycaemic control in children with type 1 diabetes mellitus","volume":"60","author":"Samandari","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.xcrm.2024.101591_bib38","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1007\/s00125-020-05237-x","article-title":"Plasma circulating miR-23\u223c27\u223c24 clusters correlate with the immunometabolic derangement and predict C-peptide loss in children with type 1 diabetes","volume":"63","author":"Garavelli","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.xcrm.2024.101591_bib39","article-title":"Serum Levels of miR-148a and miR-21-5p Are Increased in Type 1 Diabetic Patients and Correlated with Markers of Bone Strength and Metabolism","volume":"4","author":"Grieco","year":"2018","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.xcrm.2024.101591_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/srep31479","article-title":"Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study","volume":"6","author":"Seyhan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2024.101591_bib41","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89656","article-title":"Profiling of circulating microRNAs in children with recent onset of type 1 diabetes","volume":"2","author":"Erener","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2024.101591_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191067","article-title":"Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes","volume":"13","author":"\u00c5kerman","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2024.101591_bib43","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/pedi.12783","article-title":"Temporal dynamics of serum let-7g expression mirror the decline of residual beta-cell function in longitudinal observation of children with type 1 diabetes","volume":"19","author":"Ma\u0142achowska","year":"2018","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.xcrm.2024.101591_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.diabres.2018.03.044","article-title":"MicroRNA expression profile in plasma from type 1 diabetic patients: Case-control study and bioinformatic analysis","volume":"141","author":"Assmann","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.xcrm.2024.101591_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8406438","article-title":"Decreased Serum microRNA-21, microRNA-25, microRNA-146a, and microRNA-181a in Autoimmune Diabetes: Potential Biomarkers for Diagnosis and Possible Involvement in Pathogenesis","volume":"2019","author":"Liu","year":"2019","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.xcrm.2024.101591_bib46","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00109-015-1296-9","article-title":"miR-375 gene dosage in pancreatic \u03b2-cells: implications for regulation of \u03b2-cell mass and biomarker development","volume":"93","author":"Latreille","year":"2015","journal-title":"J.\u00a0Mol. Med."},{"key":"10.1016\/j.xcrm.2024.101591_bib47","article-title":"miRNA-375 a Sensor of Glucotoxicity Is Altered in the Serum of Children with Newly Diagnosed Type 1 Diabetes","volume":"2016","author":"Marchand","year":"2016","journal-title":"J.\u00a0Diabetes Res."},{"key":"10.1016\/j.xcrm.2024.101591_bib48","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s00125-018-4559-5","article-title":"Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes","volume":"61","author":"Lakhter","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.xcrm.2024.101591_bib49","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00592-019-01297-7","article-title":"Circulating miRNA-375 levels are increased in autoantibodies-positive first-degree relatives of type 1 diabetes patients","volume":"56","author":"Bertoccini","year":"2019","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.xcrm.2024.101591_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90856-6","article-title":"Insulin micro-secretion in Type 1 diabetes and related microRNA profiles","volume":"11","author":"Januszewski","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2024.101591_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100606","article-title":"Protocol to analyze circulating small non-coding RNAs by high-throughput RNA sequencing from human plasma samples","volume":"2","author":"Grieco","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.xcrm.2024.101591_bib52","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/s13063-022-06259-z","article-title":"INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes","volume":"23","author":"Dunger","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.xcrm.2024.101591_bib53","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/wrna.1120","article-title":"Potential pitfalls in microRNA profiling","volume":"3","author":"Chugh","year":"2012","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.xcrm.2024.101591_bib54","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jmoldx.2021.12.006","article-title":"Small RNA-Sequencing for Analysis of Circulating miRNAs: Benchmark Study","volume":"24","author":"Androvic","year":"2022","journal-title":"J.\u00a0Mol. Diagn."},{"key":"10.1016\/j.xcrm.2024.101591_bib55","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/nar\/gkt1021","article-title":"Biases in small RNA deep sequencing data","volume":"42","author":"Raabe","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2024.101591_bib56","first-page":"1133","article-title":"Evaluation of methodologies for microRNA biomarker detection by next generation sequencing","volume":"15","author":"Coenen-Stass","year":"2018","journal-title":"RNA Biol."},{"key":"10.1016\/j.xcrm.2024.101591_bib57","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s12864-019-5826-7","article-title":"A comparison of RNA extraction and sequencing protocols for detection of small RNAs in plasma","volume":"20","author":"Wong","year":"2019","journal-title":"BMC Genom."},{"key":"10.1016\/j.xcrm.2024.101591_bib58","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0377-0427(87)90125-7","article-title":"Silhouettes: A graphical aid to the interpretation and validation of cluster analysis","volume":"20","author":"Rousseeuw","year":"1987","journal-title":"J.\u00a0Comput. Appl. Math."},{"key":"10.1016\/j.xcrm.2024.101591_bib59","doi-asserted-by":"crossref","first-page":"D179","DOI":"10.1093\/nar\/gkac884","article-title":"isomiRdb: microRNA expression at isoform resolution","volume":"51","author":"Aparicio-Puerta","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2024.101591_bib60","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1210\/en.2012-1744","article-title":"Circulating miR-375 as a biomarker of \u03b2-cell death and diabetes in mice","volume":"154","author":"Erener","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.xcrm.2024.101591_bib61","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00125-017-4294-3","article-title":"Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes","volume":"60","author":"Snowhite","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.xcrm.2024.101591_bib62","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2337\/db20-0817","article-title":"Baseline assessment of circulating microRNAs near diagnosis of type 1 diabetes predicts future stimulated insulin secretion","volume":"70","author":"Snowhite","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2024.101591_bib63","article-title":"Influence of Disease Duration on Circulating Levels of miRNAs in Children and Adolescents with New Onset Type 1 Diabetes","volume":"4","author":"Samandari","year":"2018","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.xcrm.2024.101591_bib64","article-title":"From disease and patient heterogeneity to precision medicine in type 1 diabetes","volume":"9","author":"den Hollander","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.xcrm.2024.101591_bib65","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.trsl.2022.03.008","article-title":"Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside","volume":"247","author":"Grieco","year":"2022","journal-title":"Transl. Res."},{"key":"10.1016\/j.xcrm.2024.101591_bib66","article-title":"Novel subgroups of type 2 diabetes based on multi-Omics profiling: an IMI-RHAPSODY Study","author":"Li","year":"2022","journal-title":"medRxiv"},{"key":"10.1016\/j.xcrm.2024.101591_bib67","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12920-016-0179-4","article-title":"A microRNA biomarker of hepatocellular carcinoma recurrence following liver transplantation accounting for within-patient heterogeneity","volume":"9","author":"Xie","year":"2016","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.xcrm.2024.101591_bib68","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41416-018-0221-8","article-title":"Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences","volume":"119","author":"Kruger","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xcrm.2024.101591_bib69","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/bjd\/ljad137","article-title":"Validation of a microRNA liquid biopsy assay for diagnosis and risk stratification of invasive cutaneous melanoma","volume":"189","author":"Van Laar","year":"2023","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.xcrm.2024.101591_bib70","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/978-1-4939-7778-9_25","article-title":"Quantification of circulating microRNAs by droplet digital PCR","volume":"1768","author":"Ferracin","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2024.101591_bib71","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s00125-015-3672-y","article-title":"Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes","volume":"58","author":"Giannopoulou","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.xcrm.2024.101591_bib72","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2337\/dc18-2282","article-title":"Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report","volume":"42","author":"Krischer","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xcrm.2024.101591_bib73","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ccell.2014.10.018","article-title":"The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T\u00a0cell effector function","volume":"26","author":"Johnston","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2024.101591_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005349","article-title":"TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection","volume":"12","author":"Chew","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2024.101591_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aai7793","article-title":"Partial exhaustion of CD8 T\u00a0cells and clinical response to teplizumab in new-onset type 1 diabetes","volume":"1","author":"Long","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2024.101591_bib76","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/eji.201545708","article-title":"Changes in T-cell subsets identify responders to FcR-nonbinding anti-CD3 mAb (teplizumab) in patients with type 1 diabetes","volume":"46","author":"Tooley","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2024.101591_bib77","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00125-012-2753-4","article-title":"Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial","volume":"56","author":"Herold","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.xcrm.2024.101591_bib78","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101591_bib79","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142680","article-title":"Exhausted-like CD8+ T\u00a0cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjects","volume":"6","author":"Diggins","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2024.101591_bib80","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1172\/JCI126595","article-title":"Autoreactive CD8+ T\u00a0cell exhaustion distinguishes subjects with slow type 1 diabetes progression","volume":"130","author":"Wiedeman","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2024.101591_bib81","doi-asserted-by":"crossref","first-page":"936","DOI":"10.2337\/db17-1390","article-title":"Detection and characterization of CD8+ autoreactive memory stem T\u00a0cells in patients with type 1 diabetes","volume":"67","author":"Vignali","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2024.101591_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.715","article-title":"The frequency of CD4+ and CD8+ circulating T stem cell memory in type 1 diabetes","volume":"10","author":"Fazeli","year":"2022","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.xcrm.2024.101591_bib83","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ijc.26052","article-title":"MEG3 imprinted gene contribution in tumorigenesis","volume":"129","author":"Benetatos","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.xcrm.2024.101591_bib84","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng.493","article-title":"The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes","volume":"42","author":"Wallace","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2024.101591_bib85","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00001-17","article-title":"let-7 Contributes to Diabetic Retinopathy but Represses Pathological Ocular Angiogenesis","volume":"37","author":"Zhou","year":"2017","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2024.101591_bib86","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.2337\/db16-1405","article-title":"Protective Effect of let-7 miRNA Family in Regulating Inflammation in Diabetes-Associated Atherosclerosis","volume":"66","author":"Brennan","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2024.101591_bib87","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.imbio.2012.08.276","article-title":"MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes","volume":"218","author":"Salas-P\u00e9rez","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.xcrm.2024.101591_bib88","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2337\/dc22-1441","article-title":"Circulating small noncoding RNA profiling as a potential biomarker of atherosclerotic plaque composition in type 1 diabetes","volume":"46","author":"Giannella","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xcrm.2024.101591_bib89","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cellimm.2009.10.012","article-title":"microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients","volume":"260","author":"Hezova","year":"2010","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.xcrm.2024.101591_bib90","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/1753-0407.12163","article-title":"Decreased miR-146 expression in peripheral blood mononuclear cells is correlated with ongoing islet autoimmunity in type 1 diabetes patients","volume":"7","author":"Yang","year":"2015","journal-title":"J.\u00a0Diabetes"},{"key":"10.1016\/j.xcrm.2024.101591_bib91","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00592-016-0961-y","article-title":"Polymorphisms in genes encoding miR-155 and miR-146a are associated with protection to type 1 diabetes mellitus","volume":"54","author":"Assmann","year":"2017","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.xcrm.2024.101591_bib92","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bbrc.2017.06.196","article-title":"Decreased expression of miR-150, miR146a and miR424 in type 1 diabetic patients: Association with ongoing islet autoimmunity","volume":"498","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xcrm.2024.101591_bib93","article-title":"\u03b2 Cell microRNAs Function as Molecular Hubs of Type 1 Diabetes Pathogenesis and as Biomarkers of Diabetes Risk","author":"Syed","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2024.101591_bib94","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/hmg\/11.13.1527","article-title":"Identification of tandemly-repeated C\/D snoRNA genes at the imprinted human 14q32 domain reminiscent of those at the Prader-Willi\/Angelman syndrome region","volume":"11","author":"Cavaill\u00e9","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xcrm.2024.101591_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003574","article-title":"MiR-433 and miR-127 arise from independent overlapping primary transcripts encoded by the miR-433-127 locus","volume":"3","author":"Song","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2024.101591_bib96","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00018-012-1080-8","article-title":"The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis","volume":"70","author":"Benetatos","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.xcrm.2024.101591_bib97","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.15252\/embj.201387038","article-title":"The miR-379\/miR-410 cluster at the imprinted Dlk1-Dio3 domain controls neonatal metabolic adaptation","volume":"33","author":"Labialle","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.xcrm.2024.101591_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055272","article-title":"The miRNA profile of human pancreatic islets and beta-cells and relationship to type\u00a02 diabetes pathogenesis","volume":"8","author":"van de Bunt","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2024.101591_bib99","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2337\/db17-0682","article-title":"The Dysregulation of the DLK1-MEG3 Locus in Islets From Patients With Type 2 Diabetes Is Mimicked by Targeted Epimutation of Its Promoter With TALE-DNMT Constructs","volume":"67","author":"Kameswaran","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2024.101591_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055064","article-title":"MicroRNA expression in alpha and beta cells of human pancreatic islets","volume":"8","author":"Klein","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2024.101591_bib101","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1096\/fj.15-273649","article-title":"Multiple microRNAs within the 14q32 cluster target the mRNAs of major type 1 diabetes autoantigens IA-2, IA-2\u03b2, and GAD65","volume":"29","author":"Abuhatzira","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.xcrm.2024.101591_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.682948","article-title":"Extracellular Vesicles in Immune System Regulation and Type 1 Diabetes: Cell-to-Cell Communication Mediators, Disease Biomarkers, and Promising Therapeutic Tools","volume":"12","author":"Grieco","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2024.101591_bib105","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2024.101591_bib103","article-title":"Beta Regression in R","volume":"34","author":"Cribari-Neto","year":"2010","journal-title":"J.\u00a0Stat. Softw."},{"key":"10.1016\/j.xcrm.2024.101591_bib104","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1037\/1082-989X.11.1.54","article-title":"A better lemon squeezer? Maximum-likelihood regression with beta-distributed dependent variables","volume":"11","author":"Smithson","year":"2006","journal-title":"Psychol. Methods"},{"key":"10.1016\/j.xcrm.2024.101591_bib106","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124002830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124002830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T20:09:54Z","timestamp":1719000594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379124002830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":106,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2666379124002830"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101591","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of\u00a0individuals with recent-onset type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101591","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101591"}}